Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

This study has been completed.
Thoratec Corporation
Information provided by (Responsible Party):
Nicholas Haglund, MD, University of Nebraska Identifier:
First received: May 6, 2011
Last updated: February 28, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)